Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of human interferon alpha-2b spray in children with herpangina
CTR20261636Phase 3Active
- Sponsor
- Anke Bio
- Start
- May 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Anterferon in herpangina, sponsored by Anke Bio. Started May 2026; status: active.
02
Drugs
Anterferon
03
Conditions
herpangina
Beyond the preview
Go deeper on CTR20261636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261636.